To confirm that KIFC2 induces tumor progression and Enza resistance dependent on NF-κB p65, we detected the effect of Enza on the proliferation of KIFC2-overexpressing PCa cells pretreated with NF-κB chemical inhibitors GSK583. The gene discussed is NFKB1; the disease is neoplasm.